Condition

Kidney Failure, Chronic

ClinicalTrials.gov condition label

Clinical trials43

Recruiting4

Common interventions25

Lead sponsors shown15

Clinical trials

43 shown

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis PatientsNCT06903559 · 2025-04-15

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseNCT06217302 · 2024-10-31

Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney DiseaseNCT05283512 · 2022-04-20

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)NCT01802034 · 2013-02-01

Empagliflozin in ESKD - A Feasibility StudyNCT05687058 · 2023-11-01

ACTIVE_NOT_RECRUITING

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative CareNCT05407272 · 2021-09-14

HOLT-ED: Holter-monitoring in End-stage Renal DiseaseNCT04876963 · 2021-09-01

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)NCT04283994 · 2021-07-26

Autonomic Nervous System Dysfunction in Patients With End-stage Kidney DiseaseNCT05278702 · 2021-04-01

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)NCT04281784 · 2020-04-23

Facilitating Communication StudyNCT03721952 · 2019-04-17

Hypoxemia in Maintenance Hemodialysis PatientsNCT03045796 · 2017-03-01

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis CentersNCT02823600 · 2016-07-01

Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant HypertensionNCT02653222 · 2016-02-01

The Effect of Liraglutide in Patients With Prediabetes and Kidney FailureNCT02284230 · 2014-12-01

Sodium Chloride and Contrast NephropathyNCT03476460 · 2014-04-01

Improving Communication About Serious IllnessNCT01933789 · 2013-09-01

Quantification of Drugs and Their Degradation ProductsNCT01828372 · 2013-05-01

Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).NCT02310061 · 2013-03-01

Efficacy and Safety of Alprostadil Prevent Contrast Induced NephropathyNCT01722513 · 2012-11-01

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal DysfunctionNCT01580046 · 2012-04-01

The Clinical Evaluation of the Dose of Erythropoietins TrialNCT00827021 · 2009-07-01

Saving Residual Renal Function Among Haemodialysis Patients Receiving IrbesartanNCT00791830 · 2009-04-01

A Safety Comparison of Iopromide and Iodixanol in Renal Impaired PatientsNCT00926562 · 2009-02-01

Renal Denervation in End Stage Renal Disease Patients With Refractory HypertensionNCT00753116 · 2008-09-01

Left Ventricular Hypertrophy and Spironolactone in End Stage Renal DiseaseNCT00548912 · 2007-10-01

N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal FailureNCT00532688 · 2007-09-01

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal TransplantNCT00446251 · 2006-12-01

Vascular Reactivity in Kidney Disease PatientsNCT00226902 · 2006-09-01

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.NCT00446459 · 2006-04-01

Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis PatientsNCT00416013 · 2005-12-01

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic NephropathyNCT00108485 · 2005-04-01

Haemodialysis Salt Reduction StudyNCT00141609 · 2004-04-01

Role of Chronic Kidney Disease in Cardiovascular DiseaseNCT00069810 · 2003-08-01

Cardiac and Renal Disease Study (CARDS)NCT00049907 · 2002-09-01

An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac SurgeryNCT00122018 · 2002-05-01

Multidisciplinary Inpatient Palliative Care InterventionNCT00325611 · 2002-04-01

Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart SurgeryNCT00244530 · 2001-06-01

Risk Factors for CV Disease in a Dialysis CohortNCT00006297 · 2000-09-01

Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)NCT00005536 · 1997-07-01

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVNCT02699736 · 1994-01-01

ENROLLING_BY_INVITATION

Fifteen Year Follow-up of 5,500 Black and 5,500 Other HypertensivesNCT00005417 · 1991-09-01

Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal FailureNCT00002047

Common interventions

EHR-based Clinician JumpstartBEHAVIORAL2 N-acetylcysteineDRUG2 PlaceboDRUG2 additional blood withdrawalsOTHER1 Alprostadil ﹠controlDRUG1 Ambulatory Blood Pressure MonitoringPROCEDURE1 Blood testBIOLOGICAL1 Changing hemoglobin concentrationPROCEDURE1 Communication Feedback Form for Patients with Serious IllnessBEHAVIORAL1 Conventional Anemia ManagementDRUG1 Empagliflozin 10 mg daily dosingDRUG1 Empagliflozin 25 mg thrice-weekly post-hemodialysis dosingDRUG1 Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose.DRUG1 Extended release niacinDRUG1 Extra-vascular lung water measurements by ultrasound (LW-US)PROCEDURE1 Facilitator-Based InterventionBEHAVIORAL1 fenoldopamDRUG1 Health Education ManualOTHER1 Holter-monitorDEVICE1 Intravenous sodium chlorideDRUG1 iodixanolDRUG1 Iodixanol (Visipaque)DRUG1 iopromideDRUG1 Iopromide (Ultravist)DRUG1 IrbesartanDRUG1

Leading sponsors

University of Washington7 National Heart, Lung, and Blood Institute (NHLBI)4 Copenhagen University Hospital, Rigshospitalet2 Alessandro Doria1 Aristotle University Of Thessaloniki1 Bayside Health1 Bo Feldt-Rasmussen1 Chinese PLA General Hospital1 Dawnmarie DeFazio1 Eastern Virginia Medical School1 Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy1 Giovanni FM Strippoli, MD1 Glaxo Wellcome1 Hospital Universitario Ramon y Cajal1 Kaiser Permanente1

Trial status mix

COMPLETED25

UNKNOWN7

RECRUITING4

WITHDRAWN3

TERMINATED2

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

Phase mix

NA13

PHASE29

PHASE35

PHASE45

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.